St. Joseph-Krankenhaus

Berlin 13088

1 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Relapsing-Remitting, Primary IgA Nephropathy

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression — Recruiting now
• A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Completed